CHMG
Chemung Financial Corporation
CHMG has a slight edge over GS overall, supported by stronger fundamentals and stronger modeled upside.
GS
The Goldman Sachs Group, Inc.
GS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CHMG Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
CHMG's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like CHMG.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
CHMG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.7x | $61.52 | -28% |
| Fair | 9x | $71.85 | -16% |
| Forward | 10x | $85.69 | — |
| Current | 11x | $85.69 | — |
| Expensive | 12x | $96.93 | +13% |
Historical ranges are pointers, not guarantees.
CHMG has the edge over GS in the historical PE scenario, which offers more potential upside but is not a forecast.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CHMG Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CHMG, with profitability improving.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
CHMG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.38 | +5.2% |
| Q3 2026 | $7.97 | +188% |
| Q2 2026 | $6.96 | +197% |
| Q1 2026 | $3.79 | -20% |
| Q4 2025 | $3.14 | -37% |
| Q3 2025 | $2.77 | -39% |
| Q2 2025 | $2.34 | -53% |
| Q1 2025 | $4.74 | -9.2% |
| Q4 2024 | $4.96 | -6.1% |
CHMG earned $7.97 per share over the past year, up 188% from the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over CHMG on earnings, with more consistent year-over-year improvement.
CHMG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $32M | +11% |
| Q2 2026 | $31.2M | +209% |
| Q1 2026 | $29.9M | +16% |
| Q4 2025 | $30.5M | +18% |
| Q3 2025 | $28.8M | +18% |
| Q2 2025 | $10.1M | -57% |
| Q1 2025 | $25.7M | +8.3% |
| Q4 2024 | $25.9M | +8.9% |
CHMG's revenue has grown year over year for five quarters in a row: $32M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 52% | +17 points |
| Q2 2026 | 36% | +123 points |
| Q1 2026 | 40% | +9.7 points |
| Q4 2025 | 36% | +7 points |
| Q3 2025 | 35% | +5.2 points |
| Q2 2025 | -87% | -114 points |
| Q1 2025 | 30% | -8.4 points |
| Q4 2024 | 29% | +9.5 points |
CHMG has the edge over GS on profitability, with a higher operating margin.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over CHMG on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
CHMG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $10.7M | -9.2% |
| Q2 2026 | $8.9M | -5.1% |
| Q1 2026 | $8.9M | +30% |
| Q4 2025 | $15.7M | +265% |
| Q3 2025 | $11.8M | +38% |
| Q2 2025 | $9.4M | +72% |
| Q1 2025 | $6.9M | -13% |
| Q4 2024 | $4.3M | +19% |
CHMG has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
CHMG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.3K shares |
| 1 year | +0.6% | +28.3K shares |
| 3 years | +2.2% | +103K shares |
| 5 years | +3.3% | +155K shares |
| Available history | -0.6% | -30K shares |
CHMG has 5M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $58,000 |
| Q2 2026 | $11,000 |
| Q1 2026 | $173,000 |
| Q4 2025 | $295,000 |
| Q3 2025 | $11,000 |
| Q2 2025 | $5,000 |
| Q1 2025 | $85,000 |
| Q4 2024 | $252,000 |
CHMG spent $537,000 buying back its own shares over the past year, up 52% from the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over CHMG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
CHMG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.6x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -14.3x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.5x | Net Cash |
CHMG has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CHMG.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has the edge over CHMG on leverage, with a lower net debt burden relative to earnings.
CHMG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 67.6 | Neutral |
| Stochastic | 70.2 | Neutral |
CHMG's weekly RSI is 68 (neutral) and its Stochastic is 70 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
CHMG PE vs Financial Services Sector
| Metric | CHMG | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 17% below |
| PE % | 74 | 63 | 11 pts above |
CHMG has the edge over GS on valuation relative to its sector.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
CHMG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $83.2 | 3% above |
| 20 week MA | $81.8 | 4.8% above |
| 50 week MA | $69.3 | 24% above |
| 100 week MA | $59.3 | 45% above |
| 200 week MA | $51.9 | 65% above |
CHMG has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
CHMG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.5 | $33.7 | -21% |
| 2021 | $33.7 | $46.5 | +38% |
| 2022 | $46.5 | $44.9 | -3.4% |
| 2023 | $44.9 | $49.8 | +11% |
| 2024 | $49.8 | $49.4 | -0.8% |
| 2025 | $49.4 | $55.3 | +12% |
| 2026 YTD | $55.3 | $85.7 | +55% |
CHMG has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.